IPP Bureau
Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis
By IPP Bureau - April 13, 2022
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
USFDA grants direct RMAT designation for the use of ExoFlo in Covid-19 related ARDS
By IPP Bureau - April 13, 2022
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies
By IPP Bureau - April 13, 2022
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells
By IPP Bureau - April 13, 2022
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
Cloudbyz partners with ClinChoice to provide integrated clinical trial management solutions
By IPP Bureau - April 13, 2022
The joint partnership, powered by Cloudbyz Clinical Research Management Platform and ClinChoice's industry-leading transformation services, will provide an end-to-end clinical research management technology platform and services to customers
Novel Covid-19 vaccine may protect the immunocompromised
By IPP Bureau - April 13, 2022
The peptide-based vaccine induces a t cell-dependent response
WeylChem inaugurates new multi-purpose custom manufacturing plant in France
By IPP Bureau - April 13, 2022
The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
Zydus to supply Sagent's caffeine citrate oral solution from Jarod
By IPP Bureau - April 13, 2022
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Venus Remedies gets CII's Responsible Export Organisation Certification
By IPP Bureau - April 13, 2022
A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess
Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine
By IPP Bureau - April 13, 2022
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Wacker, CordenPharma to produce mRNA vaccines for Germany
By IPP Bureau - April 12, 2022
Both companies have been selected for stand-by production by German government
One-dose HPV vaccine offers solid protection against cervical cancer
By IPP Bureau - April 12, 2022
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Jorge Gomez joins Moderna as Chief Financial Officer
By IPP Bureau - April 12, 2022
Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019
Carestream installs DRX Compass at Gati Diagnostic Centre
By IPP Bureau - April 12, 2022
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
PhableCare raises Rs 187 crore in Series B funding
By IPP Bureau - April 12, 2022
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
